CCRE Therapeutics, Monash University, Melbourne, Vic, Australia; Melbourne Interventional Group, Vic, Australia.
Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Int J Cardiol. 2014 Mar 1;172(1):72-5. doi: 10.1016/j.ijcard.2013.12.030. Epub 2013 Dec 22.
Clinicians and other stakeholders recognize the need for clinical registries to monitor data in order to improve the outcome and quality of care in the delivery of medical interventions. The establishment of a collaboration across the Asia Pacific Region to inform on variations in patient and procedural characteristics and associated clinical outcomes would enable regional benchmarking of quality.
AIMS & METHODS: The aims of the collaboration are a) to identify the characteristics of patients undergoing PCI across the Asia Pacific region, b) to report on outcomes of patients undergoing PCI, c) to develop an appropriate ethnic and region specific risk adjustment model for patients undergoing PCI and d) to establish a registry framework for research, education and training in the area of cardiovascular interventions across the Asia Pacific Region. Descriptive characteristics of patient undergoing PCI over a 12 month period were collated and reported.
Representatives from 27 hospitals attended the inaugural meeting with interested parties from Australia, Singapore, Malaysia and Hong Kong. In every country, males predominated PCI activity. Subjects were older and had higher rates of family history of cardiovascular disease in Australia, while Asian subjects had higher rates of diabetes, dyslipidemia and renal failure. STEMI presentation was higher in Australia than in Asia and drug eluting stent use was higher in Asia. Procedural success rates were similar across the region (>95%).
Procedural success was similar across the region despite differing patient characteristics across countries in terms of pre-procedural risk factors and clinical presentation.
临床医生和其他利益相关者认识到需要临床注册来监测数据，以改善医疗干预措施的结果和护理质量。在亚太地区建立合作关系，以了解患者和手术特点的差异以及相关的临床结果，将能够对质量进行区域基准测试。
该合作的目的是：a）确定亚太地区接受 PCI 治疗的患者的特征；b）报告接受 PCI 治疗的患者的结果；c）为接受 PCI 治疗的患者开发适当的种族和特定地区的风险调整模型；d）在亚太地区建立心血管介入研究、教育和培训的注册框架。收集并报告了接受 PCI 治疗的患者在 12 个月期间的描述性特征。
来自 27 家医院的代表参加了首次会议，来自澳大利亚、新加坡、马来西亚和中国香港的相关方也参加了会议。在每个国家，男性在 PCI 活动中占主导地位。澳大利亚的患者年龄更大，且有更高的心血管疾病家族史，而亚洲患者的糖尿病、血脂异常和肾功能衰竭发病率更高。与亚洲相比，澳大利亚的 ST 段抬高型心肌梗死发生率更高，亚洲的药物洗脱支架使用率更高。该地区的手术成功率相似（>95%）。
尽管各国在术前危险因素和临床表现方面存在患者特征差异，但该地区的手术成功率相似。
